Introduction {#S1}
============

*Trans*-acyltransferase polyketide synthases (*trans*-AT PKSs) are extremely complex bacterial enzymes that generate a large variety of natural products.[@R1] The structural diversity encountered in these polyketide metabolites is impressive and accompanied by a broad range of bioactivities with relevance as therapeutics[@R2],[@R3] and as bacterial factors of pathogenicity, symbiosis, and regulation.[@R4]--[@R6] *Trans*-AT PKS biosynthetic gene clusters (BGCs) are widely distributed throughout the bacterial kingdom ([Supplementary Fig. 1a-c and Supplementary Table 1](#SD2){ref-type="supplementary-material"}).[@R1],[@R7],[@R8] They are commonly present in bacterial groups distinct from those typically studied in natural product screening programs, including many uncultivated microbiota,[@R1],[@R9]--[@R12] but remain poorly characterized. The high frequency of architecturally novel BGCs, as well as the large number and unprecedented enzymatic components present in these PKSs,[@R1] offer rich opportunities for metabolic discovery and biotechnology ([Supplementary Fig 1b](#SD2){ref-type="supplementary-material"}). To predict natural product structures from BGCs, powerful bioinformatic tools exist that are widely used in genomic and metagenomic analyses.[@R13],[@R14] However, for *trans*-AT PKSs, which are among the most complex and catalytically diverse of all known natural product enzymes, no tool provides reliable *de novo* structural predictions.

Architecturally, *trans*-AT PKSs consist of multiple concatenated modules harboring various functional domains.[@R1] Each module usually elongates and often further modifies an enzyme-bound polyketide intermediate, which is then passed on to the next module. Biosynthesis is initiated by one or a few free-standing *trans*-acting acyltransferase enzymes (AT) that select coenzyme A-(CoA-)bound acyl building blocks, usually malonyl units, and transfer them onto an acyl carrier protein (ACP) domain present in each module. A ketosynthase (KS) domain in the same module uses this building block to elongate an incoming polyketide chain in a Claisen-like condensation reaction. Additional facultative enzymatic components, either located within the module or acting in *trans*, process the resulting β-keto intermediate further to a wide range of possible α- to γ-modified products that are the elongation substrates for the KS of the next module. Once the polyketide backbone is completely assembled, it is released from the PKS, typically catalyzed by a thioesterase (TE) domain. Additional tailoring enzymes can further modify the polyketide to produce the fully maturated metabolite. In many cases, *trans*-AT PKSs form hybrids with modular nonribosomal peptide synthetases (NRPSs).[@R1],[@R15]--[@R17]

A related assembly line-like architecture exists for the well-studied *cis*-AT PKSs, which contain intramodular AT domains instead of free-standing enzymes.[@R16] *Cis*-AT PKSs usually exhibit a domain and module architecture that correlates well with the polyketide core structure. This correlation, known as the PKS colinearity rule,[@R16] permits fairly reliable structural predictions of *cis*-AT PKS-derived polyketides. Applied to the evolutionarily distinct and functionally much more diverse *trans*-AT PKSs,[@R15] however, the colinearity concept usually generates incorrect predictions.[@R1],[@R15] Modules of *trans*-AT PKSs commonly exhibit non-canonical domain orders, novel types of domains, catalytic functions that are provided *in trans* or are apparently missing, and modules split between two proteins. Different module architectures can generate identical PKS modifications, or different chemistry can result from architecturally identical modules. Another idiosyncrasy is the ubiquitous presence of non-elongating modules (indicated by a KS^0^ in the module) that do not extend but sometimes modify the nascent polyketide backbone. As a result, some modifications can be jointly installed by two modules.[@R1]

To enable genome-based natural product mining for these challenging enzymes, we previously developed a metabolic prediction method that can be applied to even highly aberrant *trans*-AT PKS systems.[@R15] It is based on a close correlation between KS sequence features and the polyketide modifications introduced by domains of the upstream PKS module, i.e., the structural features of a polyketide intermediate within the α-to-γ-region.[@R15] At least in part, this correlation is based on a high specificity of KSs for their incoming substrates that might promote coevolution of upstream modifying domains and the accepting KS domain.[@R18]--[@R21] By exploiting this correlation of KS sequence and polyketide moiety, a phylogenetic analysis of all KS domains present in *trans*-AT PKS systems reveals the collective structural information of the core polyketide. The power of this method to accurately predict canonical as well as non-canonical polyketide features has been demonstrated in various genome mining studies.[@R11],[@R15],[@R22],[@R23] To date, however, predictions require laborious KS correlations to reference trees containing a large number of KS homologs with manually assigned substrates, for which detailed biosynthetic knowledge is required.

To make such metabolic predictions accessible to a broad community, we here report the automated TransATor (*Trans*-AT PKS Polyketide Predictor) prediction pipeline. Using the PKS sequences as input, TransATor generates KS specificity predictions and, based on these, full structural proposals of the corresponding core polyketide. In addition to this new pipeline, we present several examples for applications that demonstrate the utility of TransATor in targeted polyketide discovery, generation of biosynthetic models, dereplication studies, and as a structure elucidation aid.

Results {#S2}
=======

Global analysis of *trans*-AT PKSs refines correlation rules {#S3}
------------------------------------------------------------

As a first basis for the development of an automated tool, we manually assessed the number of different modules encountered in all 54 *trans*-AT PKSs with characterized products (status October 2016).[@R1] This analysis resulted in more than 160 different module types for these systems ([Supplementary Fig. 2](#SD2){ref-type="supplementary-material"}), a striking number when compared to the few module architecures known from *cis*-AT PKSs. In terms of module frequencies, hydroxyl- and double bond-generating modules are the most diverse and abundant module types. More interestingly, non-textbook modules that introduce different forms of β-branches and double bonds containing an α-methyl group, as well as the minimal non-elongating modules (KS^0^ ACP) are also amongst the most abundant module types. Since PKS modules are usually encoded by more than one gene within a BGC, we next explored whether the biosynthetic module order is reflected in the gene order. Of the 54 BGCs, only eight do not exhibit a colinear architecture ([Supplementary Fig. 3](#SD2){ref-type="supplementary-material"}). Thus, the assumption that biosynthetic genes in the BGC are ordered in a colinear fashion would in most cases permit prediction of polyketide structures.

Previous phylogenetic analyses of *trans*-AT PKSs revealed that KSs form clades that tightly correlate with the chemical structure of their substrates,[@R1],[@R15] here referred to as ketide clades. To maximize the predictive resolution of this correlation, we chemically assigned and phylogenetically analyzed all 655 KS sequences from the 54 BGCs, resulting in a tree that contained \>90 clades ([Fig. 1](#F1){ref-type="fig"}, [Supplementary Dataset 1](#SD3){ref-type="supplementary-material"} and [Supplementary Tables 2-3](#SD2){ref-type="supplementary-material"}). The analysis confirmed many previously detected ketide clades, some of which had contained only few KS sequences.[@R15],[@R22] Other ketide clades reported in the initial study now formed subclades (i.e., for starters, β-branches, double bonds, and α-substituted β-hydroxyl moieties) that revealed more detailed structural correlations. Some clades matched to highly differentiated stereochemical or regiochemical features (e.g., L-OH or D-OH; α,β- or β,γ-double bonds). Distinct clades also emerged that permit the distinction of β-methyl branches, β-exomethylene groups, and β-branches generated by Michael-type addition.[@R18],[@R24] Remarkably, separate ketide clades were also identified for various non-acetate starter units, including aromatic-, lactate-, amino acid-, aminotransferase- (AMT) and 1,3-bisphosphoglycerate-derived starters. In addition to these subclades, manual assignment of KSs resulted in the identification of ketide clades for new types of modifications, including hemiacetals, backbone-inserted oxygen, and α,β-hydroxyl groups. The latter two modifications were previously speculated to be introduced in post-PKS tailoring reactions.[@R2],[@R25] The presence of a KS from an α-hydroxyl clade two modules upstream of a KS from a cyclic ether clade can be used to distinguish furan from pyran-type ether moieties. Furan-type rings are putatively biosynthesized by intramolecular oxa-conjugate addition of an α-hydroxyl-group introduced two modules upstream, while pyran-type rings form by addition of a canonical hydroxyl group derived from β-ketoreduction.[@R19] The existence of ketide clades for α,β-hydroxyl groups therefore suggests that some of these moieties are introduced by α-hydroxylation during chain elongation. As for elongating KSs, distinct ketide clades were also identified for non-elongating KSs (KS^0^s). The identification of clades for a wide range of common and rare biosynthetic moieties suggested remarkable predictive potential, in addition to their informative value about biosynthetic timing.

Development of the TransATor bio-/chemoinformatics pipeline {#S4}
-----------------------------------------------------------

On the basis of the ketide clade assignments, we developed TransATor ([Fig. 2](#F2){ref-type="fig"}). With a concatenated PKS protein sequence in FASTA format as input, the software annotates every defined KS clade and all other common PKS domains by comparison to custom-built Hidden Markov Models (HMMs).[@R26] In addition to the domain set classically identified in available BGC annotation tools, TransATor detects further domains predominantly present in *trans*-AT PKSs, e.g., acyl-hydrolase (AH), enoyl-CoA hydratase (ECH; syn. crotonase), branching (B), C~3~-acyltransferase (FkbH), methyltransferase (FkbM), aminotransferase (AMT) domains, and Baeyer-Villiger monooxygenases (OX). The search for EMBOSS fuzzpro patterns in KR domains is used to predict the absolute hydroxyl stereochemistry ([Supplementary Fig. 4](#SD2){ref-type="supplementary-material"}). Adenylation domain specificity predictions (NRPSpredictor2[@R27]) were implemented to account for NRPS-PKS hybrid annotations. Ultimately, a Java program generates the predicted polyketide structure based on the annotated core PKS proteins making use of the Chemistry Development Kit (CDK) ([Fig. 2](#F2){ref-type="fig"}).[@R28] First, the core structure is generated based on the ketide classification of all KS sequences. In a second pass, the linear polyketide is modified based on contextual rules. If applicable, amino acid side chains are added, as determined by NRPSpredictor2. Since the *trans*-AT PKS correlation rule is based on the correlation of a KS sequence with the modification introduced into the nascent polyketide by the module upstream of a KS, ketide moieties cannot be predicted in the absence of a downstream KS after the final module or preceding NRPS- or *cis*-AT PKS modules.[@R1] In such cases, *cis*-AT colinearity rules are used. TransATor can be remotely accessed through a web interface ([http://transator.ethz.ch](http://transator.ethz.ch/)) written in Java, which relies on BioJS components to display the KS clade, domain annotations, and stereochemical information. An interactive HTML5 page is used for the user-friendly visualization of the output ([Fig. 3](#F3){ref-type="fig"}). The predicted chemical structures are shown as images and as SMILES ([Fig. 3b](#F3){ref-type="fig"}). To estimate the level of confidence for each monomer assembled to the final predicted structure, a grey scale (black: high confidence, grey: low confidence) is used for the structural representation of the predicted polyketide. Biosynthetic domains are displayed in an annotation panel with the top five hits of the KS specificity prediction shown for each KS domain in the panel as well as in a table, including HMMs e-values and predicted substrates ([Fig. 3c](#F3){ref-type="fig"}). The top hit is used for structural prediction. Sequence information of enzymatic domains and fuzzpro patterns can be retrieved by clicking on the respective annotation.

Verification of the TransATor workflow {#S5}
--------------------------------------

To test the accuracy of the web application, we used several *trans*-AT PKS sequences with known polyketide products. [Figure 3](#F3){ref-type="fig"} shows the output generated for the *trans*-AT PKS responsible for dihydrobacillaene (**1**) biosynthesis as an example. Dihydrobacillaene, the direct product of the bacillaene PKS, is converted to bacillaene (**2**) in a tailoring reaction.[@R29],[@R30] The actual structure of **1** contains several non-canonical features like the presence of shifted double bonds installed at the β,γ-position by different mechanisms,[@R31],[@R32] a fully saturated moiety introduced by module 2 that according to textbook colinearity rules (KS-DH-KR-ACP) would generate a double bond, and a β-branch for module 6 without optional domains that would classically match to a keto function. All moieties as well as the two NRPS building blocks of **1** were correctly predicted by TransATor. The only difference between the predicted and actual product of the bacillaene PKS results from the colinearity rule-based prediction of the last incorporated moiety and the ambiguous acyl starter. The comparison between a representative selection of TransATor-based structure predictions and the reported structure for a given pathway revealed \>90% accuracy of TransATor predictions ([Supplementary Table 4](#SD2){ref-type="supplementary-material"}) for PKSs in the initial training data set and \>82% for *trans*-AT PKS-derived polyketides not part of the initial training set (BGCs published between 2017 and Nov. 2018), notably outperforming antiSMASH4.0 and PRISM3-based predictions ([Supplementary Table 5](#SD2){ref-type="supplementary-material"}).

Using TransATor as a dereplication and structure elucidation aid {#S6}
----------------------------------------------------------------

To assess the potential of TransATor for applications in natural product research, we next focused on uncharacterized *trans*-AT PKSs. An investigation of BGCs in chemically poorly explored taxa suggested the Oceanospirillales bacterium *Gynuella sunhinyii* YC6258, isolated from the rhizosphere of a *Carex* sp. plant in a marine tidal flat, as a putatively rich polyketide producer. Its genome contains the remarkable number of six *trans*-AT PKS BGCs. Analysis of one of the BGCs ([Supplementary Table 6](#SD2){ref-type="supplementary-material"}) resulted in a small but high-confidence substructure corresponding to the N-terminal section of the PKS ([Supplementary Fig. 5](#SD2){ref-type="supplementary-material"}), whereas several KSs of the C-terminal part could not be unambiguously assigned. Subjecting the high-confidence part (**3**) to a substructure search in the natural product database AntiMarin[@R33],[@R34] provided tartrolons as the only hits ([Supplementary Fig. 5](#SD2){ref-type="supplementary-material"}). Comparison with the characterized tartrolon BGC indeed pointed to the production of a tartrolon-like polyketide. Tartrolons show antibacterial activities and were isolated from bacteria of various phyla, including the γ-proteobacterial shipworm symbiont *Teredinibacter turnerae*, the source of the first described tartrolon BGC.[@R35] To test whether the predicted polyketide fragment is indeed responsible for the production of tartrolon-type compounds, *G. sunshinyii* was cultivated for chemical analysis. In total, three candidate compounds that either directly matched the mass of tartrolon D or differed by two or four Da were identified and subsequently isolated. Their structures were determined by 2D NMR experiments ([Supplementary Fig. 6-7](#SD2){ref-type="supplementary-material"}, [Supplementary Note Fig. 1-15 and Supplementary Note Table 1](#SD1){ref-type="supplementary-material"}), revealing the three tartrolons **4**, **5**, and **6** ([Supplementary Fig. 5](#SD2){ref-type="supplementary-material"}). While **4** is identical to tartrolon D, the new congeners **5** and **6** differ by substitutions of one or both of the C9 and C9' keto groups with a hydroxyl group and were hence named tartrolon F and G, respectively. **4**, **5** and **6** showed antibacterial activity against *Bacillus subtilis* (MIC values: 0.38 μM for tartrolon D, 0.38 μM for tartrolon F and 1.9 μM for tartrolon G). The isolation of tartrolon-like polyketides from another unusual producer shows that TransATor can be used for early-stage *in silico* dereplication studies, to identify new variants of polyketides of interest, and to pinpoint new producers for difficult-to-access polyketides.

As the next test case, we mined genomes of the Institut Pasteur\'s cyanobacterial strain collection (PCC collection) for the presence of *trans*-AT PKS BGCs.[@R36] This analysis revealed a 91 kb *trans*-AT PKS gene cluster (termed *lept* cluster) in the genome of *Leptolyngbya* sp. PCC 7375 ([Fig. 4a](#F4){ref-type="fig"} and [Supplementary Table 7](#SD2){ref-type="supplementary-material"}). We subjected this cluster to TransATor analysis and used the predicted structure (**7**) for a similarity search in natural product libraries. AntiMarin hits suggested partial similarity to two polyketides: the potent brine shrimp toxin phormidolide[@R37] (**8**) and oscillariolide (**9**), ([Fig. 4b](#F4){ref-type="fig"}), an inhibitor of starfish egg development.[@R38] However, the predicted compound differed from **8** and **9** in the size and structure of the macrocycle, suggesting a new polyketide core.

To test the prediction, we analyzed *Leptolyngbya* sp. PCC 7375 cultures guided by the predicted mass, chemical composition, and the putative presence of a halogen atom in the polyketide, as indicated by a halogenase gene in the BGC. Only after three months of cultivation, three candidate compounds **10--12** were identified and subjected to chromatographic separation. MS and NMR data suggested **10** to be a monobrominated polyketide that we named leptolyngbyalide A, while leptolyngbyalides B (**11**) and C (**12**) lack bromine, and **12** additionally differs in the exchange of an enolether moiety for a methyl ketone ([Fig. 4c](#F4){ref-type="fig"}, [Supplementary Fig. 8-9](#SD2){ref-type="supplementary-material"}, [Supplementary Note Fig. 16-32, and Supplementary Note Table 2](#SD1){ref-type="supplementary-material"}). Unexpectedly, **10--12** did not feature the predicted 12-membered macrolactone ring but the 14-membered oscillariolide macrolactone moiety. To address this discrepancy, we conducted PCR experiments to test for the presence of an additional PKS module that might have been missed during genome assembly ([Supplementary Fig. 10](#SD2){ref-type="supplementary-material"}). However, the PCR data did not support this hypothesis, suggesting that one module is used iteratively to give rise to the oscillariolide-like macrolactone ring. Since no BGC has been identified for oscillariolide, it is unknown whether its PKS also contains this aberrant feature. Due to the low amounts of **10**--**12** in the culture, the absolute configuration could not be determined to verify the TransATor-based stereochemical predictions. The TransATor output of the *lept* and the related *phor* PKSs resulted in virtually the same predicted configurations for all nine shared hydroxyl-bearing stereocenters of phormidolide and leptolyngbyalide ([Supplementary Table 8](#SD2){ref-type="supplementary-material"}). To our surprise, however, these predicted configurations were opposite to those reported for phormidolide.[@R39] Reanalysis of the published data for phormidolide[@R36],[@R39] showed that the Mosher ester analysis was interpreted opposite to the convention.[@R37],[@R39] These observations suggest that the stereochemistry might need to be revised ([Supplementary Fig. 11](#SD2){ref-type="supplementary-material"}).

TransATor-based discovery of a new polyketide scaffold {#S7}
------------------------------------------------------

To test whether TransATor can be used to discover natural products with novel skeletons from chemically unexplored bacterial groups, we selected a *trans*-AT PKS from a sponge-derived *Aquimarina* sp. bacterium, a member of the phylum Bacteroidetes. Several KS sequences from *trans*-AT PKSs were previously PCR-amplified from *Aquimarina* strains isolated from *Irciniidae* sponges by homology-based gene targeting.[@R40] We therefore selected such *trans*-AT PKS-positive strains for genome sequencing. One of the identified *trans*-AT PKS BGCs (here termed *cun*) stood out ([Fig. 5a](#F5){ref-type="fig"} and [Supplementary Table 9](#SD2){ref-type="supplementary-material"}), as it was conserved among several strains and contained a module with two non-canonical domains (DUF PLP), of which homologs participate in the formation of a sulfur heterocycle pharmacophore in leinamycin-type compounds.[@R41] Apart from this feature, however, the *cun* and leinamycin PKSs show little resemblance. To conduct targeted isolation of the predicted polyketide (**13**) ([Fig. 5](#F5){ref-type="fig"}), we cultivated *Aquimarina* spp. Aq349 and Aq78. However, despite extensive variation of cultivation conditions, we were unable to identify a metabolite at the predicted mass and chemical composition range. Since the predicted structure contains three exomethylene groups that would generate characteristic NMR shifts, we aimed to identify the metabolite using an NMR-guided isolation strategy. These efforts resulted in the purification of two candidate natural products **14** and **15** ([Fig. 5b](#F5){ref-type="fig"}). Surprisingly, structure elucidation by 2D NMR experiments ([Supplementary Fig. 12](#SD2){ref-type="supplementary-material"}, [Supplementary Note Fig. 33-42, and Supplementary Note Tables 3-4](#SD1){ref-type="supplementary-material"}) revealed that **14** and **15** are in perfect structural agreement with the TransATor-based prediction up to module six, but are lacking the remaining polyketide portion that would correspond to PKS modules 7 to 16. The compounds, wich were produced by both strains, were named cuniculene 6A (**14**) and 6B (**15**), with the numbering chosen to indicate an early release from PKS module 6. An intriguing feature of **15** is the unique (to our knowledge) panthetheinyl moiety, likely due to non-canonical release from the PKS by phosphate ester cleavage of the phosphopanthetheinyl arm. The presence of the acyltransferase-like gene *cunR* (PSI-blast) directly downstream of the *cun* region encoding PKS module 6 indicates that the release is programmed rather than spontaneous. The biological importance of this mechanism, which would inactivate the PKS module, is currently unknown. However, the isolation of a biosynthetic intermediate that is in perfect agreement with the predicted structure shows that TransATor can be employed to target novel *trans*-AT PKS scaffolds despite the high frequency of unprecedented biosynthetic features in such enzymes.

Discussion {#S8}
==========

Known natural products generated by *trans*-AT PKSs exhibit a wide range of structures and bioactivities. These include antibiotics,[@R2],[@R42] anticancer drug candidates,[@R43],[@R44] pathogenicity factors of human[@R5],[@R45],[@R46] and agricultural relevance,[@R6],[@R47] plant protectants,[@R48] bacterial regulators,[@R4] and tools used in cell biology.[@R49] According to genomic and metagenomic data, however, much of the chemical diversity encoded by *trans*-AT PKS BGCs resides in chemically unexplored bacteria and therefore remains uncharacterized ([Supplementary Fig. 1a-c](#SD2){ref-type="supplementary-material"}). Recent studies have also revealed such *trans*-AT PKS clusters in human microbiota and pathogens, such as clostridia and *Streptococcus mutans*, raising important questions about their products and relevance for health.[@R9],[@R50] Additionally, *trans*-AT PKSs from uncultivated microbiota likely generate many, if not most, bioactive polyketides identified in marine invertebrate-based drug screening programs.[@R12],[@R25] Considering the rich opportunities provided by massively increasing DNA datasets, there is thus a need for robust automated assignments of chemical structures to *trans*-AT PKSs. Due to the extraordinary architectural diversity and non-colinear enzymology of these assembly lines (i.e., not adhering to *cis*-AT colinearity rules), such a tool was not available among the existing BGC annotation pipelines.

Here, we filled this gap by developing TransATor, a pipeline and web application for the functional assignment of *trans*-AT PKS sequences. This tool permits the structure prediction of polyketide products, thus aiding (meta)genome annotation, natural product discovery, and *in silico* dereplication. In addition, it provides insights needed for the generation of biosynthetic hypotheses, which is often challenging for these enzymes. The first publication of ketide clades that connects KS sequences with polyketide moieties describes 140 KSs and 16 clades.[@R15] Since then, structural resolution has increased simultaneously with the number of characterized PKSs (655 KS sequences and \> 90 clades identified in this work). It is reasonable to expect that third-generation sequencing in combination with TransATor-guided isolation and characterization of novel polyketides will further improve the predictive resolution in an iterative process. Although the level of accuracy in TransATor-based predictions is generally high for the examples provided in this study, ketide clades for rare substrate moieties are poorly populated (e.g. KSs for α,β-hydroxylated moieties, hemiacetals, vinylogous chain branching, or oxygen insertion). Adding further KS sequences to such clades will likely increase the reliability of TransATor-based annotations and reveal new clades. There are only a few clades that are populated by KS sequences with more than a single predicted substrate type ([Fig. 1](#F1){ref-type="fig"}). With increasing numbers of annotated KS sequences, chemically uniform subgroups might emerge, as previously observed for other clades.[@R15],[@R22] Considering the diversity of *trans*-AT PKS modules, it is likely that the discovery of further BGCs and their polyketides will require expansion of the initial training data set by additional clades. To continuously improve TransATor, updated phylogenetic trees and new cladification patterns can be implemented into the software.

The workflow demonstrated here consists of three integral parts. First, a PKS product is predicted using TransATor. Second, the predicted structure is used for natural product database searches and third, information about the predicted polyketide scaffold is used for the targeted isolation, purification, and structure elucidation of the corresponding polyketide. As exemplified in this study, relevant information about the predicted polyketide that guides the isolation process can either be the chemical composition, predicted mass range, physico-chemical properties, or characteristic NMR shifts. TransATor assumes colinearity in the order of translated protein sequences used as input. In some cases, a non-colinear order of PKS proteins prevents TransATor from accurately predicting a structure (e.g. starter in the middle of the polyketide or a shifted double bond preceeding a canonical double bond). In cases where TransATor recognizes such conflicts, a troubleshooting guide in the tutorial will provide possible solutions.

The number of characterized modular PKS BGCs is lower than the number of complex polyketides that are present in natural product databases. Many of these biosynthetically unassigned polyketides exhibit structural features typical for a *trans*-AT PKS origin.[@R25],[@R33],[@R34] Thus, the strategy described here, i.e., using the TransATor-based structure predictions to search in chemical databases, might outcompete homology-based searches on the gene cluster level for dereplication studies. Using the predictions generated by TransATor for database searches, formal assignments of gene clusters to known polyketides can be made by *in silico* dereplication and subsequently experimentally confirmed.

An important application of high biotechnological value is the targeted discovery of novel producers of pharmaceutically relevant polyketides for which the producer is either unknown, genetically not accessible, uncultivated, or yields only minute amounts of the drug candidate. In these cases, the identification of a new producer of the polyketide of interest could make challenging multi-step chemical syntheses obsolete. These and other applications should make TransATor a valuable community tool.

Online Methods {#S10}
==============

Statistical analysis {#S11}
--------------------

Metadata for the relative distribution of classes of polyketides were retrieved from all polyketide BGCs identified in the antiSMASH database. The relative abundance of *trans*-AT PKS gene clusters from sequenced genomes is based on the metadata published by O'Brien *et al*. (2014) and the antiSMASH database.[@R7],[@R51] All published *trans*-AT PKS BGCs (excluding NRPS-PKS hybrid BGCs which only harbor one *trans*-AT PKS module e.g. didemnin PKS) were retrieved from Helfrich and Piel (2016) and Piel (2010).[@R1] Analysis on module architectures and co-linearity of biosynthetic genes in *trans*-AT PKS BGCs are based on the biosynthetic models reviewed and, if applicable, revised by Helfrich and Piel (2016) and Piel (2010).[@R1]

Phylogenetic analysis of KS sequences {#S12}
-------------------------------------

655 *tran*s-AT PKS KS amino acid sequences of all characterized 54 *trans*-AT PKS BGCs[@R1] were, if deposited, retrieved from public databases. Two *cis*-AT PKS KS sequences from the erythromycin PKS were used as outgroup. Sequence alignments were either conducted using the MUSCLE or MAFFT algorithm, manually refined and re-aligned. In order to find the optimal phylogenetic representation, the "Best protein model ML and NJ" was computed in MEGA 6.4. For comparison, a RAxML tree was constructed from both MUSCLE and MAFFT alignments. The phylogenetic representations were compared with sequence similarity networks (<https://efi.igb.illinois.edu/efi-est/>). Most phylogenetic trees resulted in a comparable level of clade resolution; the trees shown in this paper were generated from MUSCLE alignments followed by phylogenetic analysis using ML trees and 1000 bootstrap replicates. The LG substitution model with Frequencies (+F) was used with rates and patterns set to gamma distribution with invariant sites (G+I) and gap treatment to complete deletion. Ketide clades were assigned manually and the resulting tree was exported in Newick format and uploaded into iTOL. Graphical representation was conducted in iTOL.[@R52]

HMM models of PKS domains commonly present in *trans*-AT PKS gene clusters {#S13}
--------------------------------------------------------------------------

Alignments of individual domains were generated from sequences retrieved from our in house database of annotated *trans*-AT PKS BGCs, the MIBiG database or GenBank.[@R53] Sequences were aligned using the MUSCLE algorithm, and the resulting alignment was manually refined. HMM models were generated using the HMMER3 suite. Cutoff values for the HMM models were determined manually by comparing characterized PKS with the TransATor output at different cutoffs for each domain.

EMBOSS fuzzpro patterns {#S14}
-----------------------

The KS phylogeny-based stereochemical predictions are verified by an EMBOSS fuzzpro pattern (EMBOSS:6.6.0.0) in the KR domain upstream of the module that harbors the KS domain relevant for the prediction of the monomer in question. The relevant fuzzpro pattern is detected approximately 80 amino acids downstream of the general KR motif: GG\[ALVMTGS\]G \[GRYDAVTHSK\]\[LIV\]G. The detection of the motif GXXHXAXXXXD indicates the formation of a D-OH group (fuzzpro \[GDPSERVIHKNAT\]x(3)\[GVTA\]\[IVAL\]\[VHILF\]\[HYFVQY\]\[SIATGMLCFNV\]\[AVTPS\]\[GLIMRP\]x(3)D). In the absence of the characteristic aspartate residue, the introduced hydroxyl group is L-configured.

TransATor software development {#S15}
------------------------------

The program is composed of two applications: a core, mainly focused on sequence annotation, and a second application handling molecule rendering and user interaction. The core, written in Python 2.8, takes a query in FASTA format. It runs HMMER, NRPSpredictor2, EMBOSS Fuzzpro against the query, and collects the results. The results are consolidated into a format wide enough to include all types of annotations, and written to disk as a \".features\" file. The HMMER3 suite was used to pre-train the profile HMM models based on manually retrieved sequences which were aligned using the MUSCLE algorithm. Models for the following domains were created: KS (90 clades, 655 sequences), KR (248 sequences), DH (149 sequences), ER (12 sequences), MT (82 sequences), O-MT (11 sequences), A (142 sequences), TE (28 sequences), Enoyl-CoA hydratase (ECH; 20 sequences), epimerase (E; 15 sequences), condensation (C; 189 sequences), ACP (460 sequences), GNAT (8 sequences), flavin-dependent monooxygenase (FMO; 6 sequences), AT/AH (47 sequences), acyl ligase (AL; 3 sequences), cyclase (Cyc; 10 sequences), pyran synthase (PS; 12 sequences) and branching domains (5 sequences).

The second application is written in Java 1.8 and has two main functions: molecule rendering and user interaction. The user interaction is built in two parts: A Servlet handling user input of the sequence query, and a REST API providing the results. Two input formats are supported: a textbox, and a file upload. After a successful submission of the input query a \"results\" page is served. This page polls a REST API for a PNG picture of the predicted polyketide molecular structure, SMILES data thereof and the data for the visualization of the annotation clustering. The BioJS library ([https://biojs.net/](https://biojs.net/#/)) is used for said visualization.

The molecule rendering starts by running the core with the query, and parsing the resulting \".features\" file. The annotations describing PKS domains (of HMMER origin) are filtered so that only annotations with a score value above a fixed threshold remain. The threshold for HMMER-based annotations was optimized for every domain annotation.

The annotations are clustered by their location in the query protein sequence with DBSCAN (version 1.1-3):[@R54] non-overlapping regions are tolerated up to a distance of 40 amino acids. Within each cluster, the annotations are sorted by predicted score, and the annotation with the highest score is selected for further processing. This method of selecting relevant annotations from a regional cluster has also been referred to as \"Best Match Cascade\" in the literature.[@R55]

The molecule rendering code processes the filtered and selected annotations in the order they appear in the query sequence. Depending on the type of annotation, different actions are taken. The most important type of domain annotations for the prediction of the molecular structure are elongating ketosynthase domains (KS): they determine the next monomer to be incorporated into the growing polyketide structure. For them a function implementing said elongation is called. All other domains leading up to a KS domain provide additional information relevant to the elongation step and therefore are stored for later processing. This information is later used to modify a predicted monomer before its incorporation into the growing polyketide. We call this step "preprocessing". E.g. preprocessing of an amino acid monomer is conducted as follows: A base structure which does not include the amino acid specific side chain, is modified by a \"NRPSMonomerProcessor\" that adds the corresponding chain as predicted by NRPSpredictor2 before it is incorporated. After each elongating step, this list of non KS domain annotations is cleared.

The algorithm for the elongation of the molecular prediction works by merging CDK (version 2.0) IAtomContainer typed objects at special points denoted by so called \"pseudo atoms\". These atoms do not represent real atoms, but can be incorporated into structures as metadata. We use two pseudo atoms: \"R1\" and \"R2\". "R1" denotes where the monomer should be attached to the growing polyketide structure prediction, and \"R2\" denotes where the following monomer will be attached. The algorithm looks for the "R2" pseudo atom in the growing polyketide and for the R1 pseudo atom in the monomer to be added. It then removes these pseudo atoms with their corresponding bonds and connects the C-atoms to which the pseudo atoms were connected to each other instead. Finally, the implicit hydrogen atom count is adjusted to the number of hydrogens present at the carbon atoms involved in the novel bond.

KS domains that correlated with furan and pyran rings as their predicted substrates: Forming the ring requires the modification of a monomer which was incorporated two monomers upstream. When such a KS domain is processed, the algorithm registers a \"PostProcessor\" which is run after it has processed all annotations in a linear fashion. In this case, a \"CyclizationPostProcessor\" finds the two atoms involved in the ring forming reaction across multiple monomers and connects them accordingly.

However, relying on substrate specificity of the incoming intermediates for the final structure prediction also bears a problem. The KS domains select for the structure created, or modified by the upstream domains, and hence cannot be used for the prediction of modifications downstream of the last KS domain. To predict the effects of these domains, we use a co-linearity rule-based approach. We determine the set of the non-KS domain types that follow the last elongating KS domain. For each set, a fixed mapping to a monomer is defined that is then incorporated at the termination boundaries.

A similar problem occurs in hybrid PKS-NRPS BGCs: The effects of the domains between a KS domain and a NRPS module, cannot be predicted with the KS substrate specificity, and is handled in the same way as described above.

Finally, the individual monomers in the predicted structure are colored in a grey scale according to the confidence of the algorithm for the predicted monomer substrate of the corresponding KS. A combination of e-value of the top hit and the difference of the e-value of the top hit in comparison to the second top hit is used as a basis for the color coding.

Organisms and culture conditions {#S16}
--------------------------------

*Gynuella sunshinyii* YC6258 was cultured in marine broth 2216 in 1 L ultra-high yield flasks for 3 days at 30 °C at 120 rpm. *Leptolyngbya* sp. PCC 7375 was cultured in 40 mL ASNIII medium at room temperature for 2 up to 8.5 months exposed to a 13 h-11 h light-dark cycle at 20 μmol photon.m^-2^.s^-1^. *Aquimarina* sp. 78 and *Aquimarina* sp. 349 were cultured in marine broth 2216 (BD Difco™) in 1 L ultra-high yield™ flasks (Thomson) for 2 or 3 days at 25 °C at 160 rpm. Cultures volumes were scaled up to determine the structure of the compounds.

Genome sequencing and annotation {#S17}
--------------------------------

*Aquimarina* sp. Aq78 and *Aquimarina* sp. 349 were retrieved from the marine sponge *Sarcotragus spinosulus* as described previously.[@R56] Prior to whole genome sequencing, genomic DNA was extracted from a pure culture grown in marine broth for five days at 19 °C using the Wizard Genomic DNA Purification kit (Promega Corporation, Madison, WI, USA). Paired-end sequence reads (125 bp) were generated using an Illumina HiSeq2500 platform at BaseClear (Leiden, The Netherlands). FASTQ sequence files were generated using the Illumina Casava pipeline version 1.8.3. Sequencing output was 287 Mb consisting of 2 x 128 bp quality-filtered paired-end reads, resulting in a predicted genome coverage of 48X. Adapter sequences were trimmed and the reads assembled using the CLC Genomics Workbench version 7.0.4. Initial annotation was performed with the RAST (Rapid Annotation using Subsystem Technology) server, version 2.0.[@R57] *Aquimarina* sp. Aq78 shares 98.98% 16S rRNA gene identity with type strain *Aquimarina macrocephali* JAMB N27, isolated from marine sediment.[@R58]

The genome sequences of *Leptolyngbya* sp. PCC 7375 (ALVN00000000) and *G. sunshinyii* YC6258 (NZ_CP007142.1) were obtained previously.[@R36],[@R59]

PCR-based verification of the *lept* BGC {#S18}
----------------------------------------

Polymerase chain reactions (PCRs) were performed with Phusion polymerase (Thermo Fischer Scientific) and GC buffer. The reagents for a 50 μL reaction were mixed (Phusion HC buffer (5X) 10 μl, dNTPs (10 mM each) 2 μL, primers (10 μM each) 2 μL each, DMSO 1.5 μL, phusion polymerase 0.5 μL, DNA 20-100 ng and the thermocycler program set as follows: initial denaturation 2 min at 98 °C, denaturation 15 sec at 98 °C, annealing 20 sec at 68 °C, extension 3 min at 72 °C, 35 cycles.

Oligonucleotides used in this study {#S19}
-----------------------------------

  Primer name      Primer sequence
  ---------------- ----------------------------------------
  **KS13_forw.**   TGGAGAATTCTCCATTTTACGTAAATACTACGTGCCG
  **KS14_rev**     ACCAATATTGCCAGATTCGTCGGAATAATAGTCCCTC
  **KS14_forw.**   GCCTATCATTAACGGTAGGCCGAGGCGGCGCAT
  **KS15_rev.**    AGCTCCCCACTGCCCATAGATCTTGTTTGGATG
  **KS15_for.**    AGGTGCGCCGAGCCGCTGTCAGTTCCTTTG
  **C_rev.**       TGTGAATGTCAAATAACAGGCTCTGGCGTTCCTTCTGA

Isolation and structure elucidation of tartrolons D, F and G (4-6) {#S20}
------------------------------------------------------------------

A 2 L culture of *G. sunshinyii* was centrifuged, and the pellet was extracted with acetone. The extract was dissolved in MeCN, and separated by reversed-phase HPLC (Phenomonex Luna 5 μm C~18~, 10 x 250 mm, UV detection at λ = 220 nm, r.t.) eluting with 5% MeCN for 5 min, then a gradient from 5% MeCN to 100% MeCN for 30 min, and 100% MeCN for 25 min. The fraction eluting between 46-49 min was further purified by reversed-phase HPLC (Phenomenex Luna 5 μm Phenyl-Hexyl, 10 x 250 mm, UV detection at λ = 220 nm, r.t.) eluting with 65% MeCN to yield 0.9 mg of compound **4** and 1.3 mg of compound **5**. In addition, the fraction eluting between 52-55 min in the first chromatographic separation step was further purified by reversed-phase HPLC (Phenomenex Luna 5 μm Phenyl-Hexyl, 10 x 250 mm, UV detection at λ = 220 nm, r.t.) eluting with 65% MeCN to yield 1.0 mg of compound **6**.

Compound **4** had a molecular formula of C~44~H~68~O~14~, which was suggested by HR-LC-ESI-MS (*m*/*z* 843.4475, \[M+Na\]^+^, Δ-2.6 mmu). Comparison of the ^1^H NMR spectrum of compound **4** with the literature values of tartrolon D revealed its identity.

Compound **5** had a molecular formula of C~44~H~70~O~14~, which was suggested by HR-LC-ESI-MS (*m*/*z* 845.4635, \[M+Na\]^+^, Δ-2.3 mmu). Analysis of the ^1^H NMR spectrum and MS^2^ data suggested structural asymmetry consisting of a tartrolon D monomer and a highly similar second monomer that form a heterodimer. Units **a-c** were deduced by COSY data. Unit **a** was connected to unit **b** by HMBC correlations from H-7, H-8, H-10, and H-11 to C-9, and from H-10 to C-8. The hemiketal moiety in unit **b** was formed by HMBC correlations from H-4, H-5, H-7, and H-22 to C-3. Unit **b** was connected to unit **c** by HMBC correlations from H-2 to C-1, C-3, and C-4, from H-4 to C-2, and from H-20\' to C-1. The hemiketal moiety in unit **c** and the connection between unit **a** and unit **c** were determined in the same manner.

14*E* (14\'*E*) geometry was determined by NOESY correlations between H-13 (H-13\') and H-15 (H-15\'), and between H-14 (H-14\') and H-16 (H-16\'). 16*Z* (16\'*Z*) geometry was determined by the small coupling constant (^3^*J*~H16,H17~ (^3^*J*~H16\',H17\'~) = 10.8 Hz) and NOESY correlation between H-16 (H-16\') and H-17 (H-17\').

Compound **6** had a molecular formula of C~44~H~72~O~14~, which was suggested by HR-LC-ESI-MS (*m*/*z* 847.4791, \[M+Na\]^+^, Δ -2.3 mmu). Analysis of the ^1^H NMR spectrum and MS[@R2] data suggested that the structure was the homodimer of the novel half of compound **5**. The structure was confirmed by 2D NMR.

Isolation and structure elucidation of leptolyngbyalides A-C (10-12) {#S21}
--------------------------------------------------------------------

A three month old, 1.6 L culture of the cyanobacterium *Leptolyngbya* sp. PCC 7375 was filtered, and the pellet was extracted with acetone and MeOH overnight. The extract was concentrated *in vacuo*, and the residue was resuspended in 90% MeOH and extracted with *n*-hexane. The 90% MeOH layer was concentrated and separated by reversed-phase HPLC (Phenomenex Luna 5C~8~, 10 x 250 mm, UV detection at λ = 220 nm, r.t.) and eluted with 5% MeCN for 5 min, then a gradient from 5% MeCN to 100% MeCN for 30 min, and 100% MeCN for 25 min. The fractions eluting after 50 min were combined and further separated by reversed-phase HPLC (Phenomenex Luna 5C~18~, 10 x 250 mm, UV detection at λ = 220 nm, at room temperature) eluted with 100% MeCN to afford fractions 1 to 12. **10**-**12** were purified from fractions 2, 8 and 9 by reversed-phase HPLC (Phenomenex Luna 5C~18~, 10 x 250 mm, UV detection at λ = 220 nm, r.t.) eluted with 95% MeOH.

Compound **12** had a molecular formula of C~56~H~98~O~12~, which was suggested by HR-LC-ESI-MS (*m*/*z* 985.6940, \[M+Na\]^+^, Δ-1.1 mmu). Analysis of the ^1^H NMR spectrum in conjunction with the HSQC data revealed the presence of six singlet methyls, three doublet methyls, one ethyl group, nine oxygenated methines, and one exomethylene. Units **a-g** were deduced by COSY data. The acetyl moiety was attached to unit **a** via an exomethylene which was determined by HMBC correlations from H-28 to C-29, C-30, and C-40, from H-31 to C-29 and C-30, and from H-40 to C-28, C-29, and C-30. Unit **a** and unit **c** were connected via unit **b** on the basis of HMBC correlations from H-23 to C-25 and C-39, from H-25 to C-23 and C-39, from H-26 to C-24, from OH-23 to C-23 and C-24, from OH-25 to C-24 and C-25, and from H-39 to C-23 and C-25. Unit **c** was connected to unit **d** via the dimethyl quaternary carbon, which was elucidated by HMBC correlations from H-19 to C-21 and C-38, from H-21 to C-19 and C-38, from OH-19 to C-19 and C-20, from OH-21 to C-20 and C-21, from H-37 to C-19, C-20, C-21, and C-38, and from H-38 to C-19, C-20, C-21, and C-37. Unit **d** and unit **e** were connected by HMBC correlations from H-15 to C-17, from H-16 to C-18 and C-36, from H-18 to C-16, C-17, and C-36, from H-19 to C-17, and from H-36 to C-16, C-17, and C-18. Unit **e** and unit **f** were connected via a methyl hydroxyl tetrahydrofuran by HMBC correlations from H-11 to C-14, from H-12 to C-14, from H-13 to C-14 and C-35, from H-15 to C-13 and C-14, and from H-35 to C-13, C-14, and C-15. Unit **f** was connected to unit **g** by HMBC correlations from H-8 to C-10, from H-10 to C-9 and C-34, and from H-34 to C-10. The macrolide was formed between the other terminus of unit **f** and unit **g**, which was determined by HMBC correlations from H-2 to C-1, C-3, C-4, and C-32, from H-4 to C-2, C-3, and C-32, from H-32 to C-2, C-3, and C-4, and from H-18 to C-1. Finally, the fatty acid was attached to C-27 as revealed by HMBC correlation from H-27 to C-41. The length of the fatty acid was deduced from the molecular formula.

The 2*E* geometry was determined by NOESY correlation between H-2 and H-4. The 16*E* geometry was determined by NOESY correlations between H-15 and H-36, and between H-16 and H-18. The relative stereochemistry of the ether ring was elucidated by NOESY correlations between H-35 and H-18, between H-18 and H-12b, and between H-12b and H-11.

Compound **11** had a molecular formula of C~57~H~100~O~12~, which was suggested by HR-LC-ESI-MS (*m*/*z* 999.7105, \[M+Na\]^+^, Δ -0.2 mmu). Analysis of the ^1^H NMR spectrum in conjunction with HSQC data suggested the absence of the acetyl group in compound **12** but the additional oxygenated methyl and an exomethylene. HMBC correlations from H-28 to C-29, C-30, and C-40, from H-31 to C-29 and C-30, from H-40 to C-28, C-29, and C-30, and from H-57 to C-30 determined the substructure, which was different from compound **12**.

Compound **10** had a molecular formula of C~57~H~99~O~12~Br, which was suggested by HR-LC-ESI-MS (*m*/*z* 1077.6213, \[M+Na\]^+^, Δ +0.1 mmu). Analysis of the ^1^H NMR spectrum in conjunction with the molecular formula and HSQC data suggested that compared to compound **11**, compound **10** lacked one hydrogen but gained one bromide at the terminal exomethylene moiety. 2D NMR data confirmed the structure. The length of the fatty acid was deduced from the molecular formula and MS2 fragmentation patterns.

Isolation and structure elucidation of compounds cuniculene 6A and 6B (14-15) {#S22}
-----------------------------------------------------------------------------

A 3 L culture of *Aquimarina* sp. Aq78 (3 days at 25 °C) was centrifuged, and the supernatant was extracted with EtOAc. The extract was dissolved in MeCN, and separated by reversed-phase HPLC (Phenomonex Luna 5 μm C~18~, 20 x 250 mm, UV detection at λ = 220 nm, r.t.) eluted with 5% MeCN for 5 min, then a gradient from 5% MeCN to 100% MeCN for 30 min, and 100% MeCN for 25 min. The fraction eluting between 22-26 min was further purified by reversed-phase HPLC (Phenomenex Luna 5 μm Phenyl-Hexyl, 10 x 250 mm, UV detection at λ = 220 nm, r.t.) eluted with 45% MeCN to yield compound **14**. A 3 L culture of *Aquimarina* sp. Aq78 (2 days at 25 °C) was centrifuged, and the supernatant was extracted with EtOAc. The extract was dissolved in MeCN, and separated by reversed-phase HPLC (Phenomonex Kinetex 5 μm C~18~, 10 x 250 mm, UV detection at λ = 220 nm, r.t.) eluted with 40% MeCN. The fraction eluting between 44-46 min was collected on ice and quickly concentrated afterwards. The fraction was further purified by reversed-phase HPLC (Phenomenex Luna 5 μm Phenyl-Hexyl, 10 x 250 mm, UV detection at λ = 220 nm, r.t.) eluted with 40% MeCN. The fraction between 46-50 min was collected on ice and dried as soon as possible to yield compound **15**. In each step, all fractions were measured by ^1^H NMR to detect the fraction containing exomethylenes.

Compound **14** had a molecular formula of C~21~H~32~O~4~, which was suggested by HR-LC-ESI-MS (*m*/*z* 371.2196, \[M+Na\]^+^, Δ-0.3 mmu). The ^1^H NMR spectrum and HSQC data of compound **8** revealed the presence of one triplet methyl, one doublet methyl, two oxygenated methines, four protons attached to sp^2^ carbons, and three exomethylenes. The three units **a-c** were deduced from the COSY spectrum. Unit **a** and unit **b** were connected by HMBC correlations from H-14 to C-15, C-16, and C-21, from H-16 to C-14, C-15, and C-21, from H-17 to C-15, and from H-21 to C-14, C-15, and C-16. Unit **b** and unit **c** were connected by HMBC correlations from H-5 to C-7, from H-6 to C-7, C-8, and C-19, from H-8 to C-6, C-7, and C-19, from H-9 to C-7, and from H-19 to C-6 and C-8. The structure of the other side of unit **c** was determined by HMBC correlations from H-2 to C-1, C-3, C-4, and C-18, from H-4 to C-2, C-3, and C-18, from H-5 to C-3, and from H-18 to C-2 and C-4. 4*E* and 8*E* geometry was determined by the large coupling constants (^3^*J*~H4,H5~ = 15.8 Hz, ^3^*J*~H8,H9~ = 15.8 Hz).

Compound **15** had a molecular formula of C~32~H~52~O~7~N~2~S~1~, which was suggested by HR-LC-ESI-MS (*m*/*z* 609.3577, \[M+H\]^+^, Δ+0.3 mmu). The ^1^H NMR spectrum and HSQC data of compound **15** revealed the presence of one triplet methyl, one doublet methyl, two singlet methyls, three oxygenated methines, one oxygenated methylene, four protons attached to sp[@R2] carbons, and three exomethylenes. Six units **a-f** and the presence of two hydroxymethines were deduced by the interpretation of the COSY spectrum. Unit **a** and unit **b** were connected by HMBC correlations from H-14 to C-15, from H-16 to C-15 and C-21, and from H-17 to C-15. Unit **b** and unit **c** were connected by HMBC correlation from H-20 to C-11. Unit **c** and unit **d** were connected by HMBC correlations from H-6 to C-7, C-8, and C-19. Unit **e** and unit **f** were connected by HMBC correlations from H-7\' and H-10\' to C-8\'. The terminus of unit **f** was determined by HMBC correlations from H-3\' to C-2\' and C-4\', from OH-3\' to C-2\' and C-4\', from H-12\' to C-1\', C-2\', C-3\', and C-13\', and from H-13\' to C-1\', C-2\', C-3\', and C-12\'. Finally, unit **d** and unit **e** were connected by HMBC correlations from H-2 to C-1, C-3, C-4, and C-18, from H-18 to C-2 and C-4, and from H-11\' to C-1. The presence of sulfur atom between C-1 and C-11\' were determined by the chemical formula, and the chemical values of C-1 and C-11\'. 4*E* and 8*E* geometry was determined by the large coupling constants (^3^*J*~H4,H5~ = 15.9 Hz, ^3^*J*~H8,H9~ = 15.9 Hz).

Antibacterial assays {#S23}
--------------------

Overnight culture of *Arthrobacter crystallopoietes*, *Bacillus subtilis*, *Escherechia coli*, and *Pseudomonas putida* grown in LB were diluted to an OD~600~ = 0.01 with LB. 200 μl aliquots were then pipetted into each well of flat-bottom 96 well plates. Compounds were added to the wells in a serial dilution along with a negative and positive control (methanol and ampicillin). The plates were incubated at 30 °C for 24 hours after which OD~600~ was measured. The respective minimum inhibitory concentration was determined as the lowest concentration at which there was no observed growth (OD~600~ ≤ 0.02).

Instrumentation {#S24}
---------------

NMR spectra were recorded on a Bruker Avance III spectrometer equipped with a cold probe at 500 MHz and 600 MHz for ^1^H NMR and 125 MHz and 150 MHz for ^13^C NMR. Chemical shifts were referenced to the solvent peaks at δ~H~ 7.27 and δ~C~ 77.23 for chloroform-*d*, δ~H~ 3.31 and δ~C~ 49.15 methanol-*d*~4~, and δ~H~ 2.50 and δ~C~ 39.51 for DMSO-*d*~6~. UPLC-HESI (HR-LC-ESI-MS) mass spectrometry was performed on a Thermo Scientific Q Exactive mass spectrometer coupled to a Dionex Ultimate 3000 UPLC system.
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![Phylogenetic separation of *trans*-AT PKS KS domains into ketide clades.\
Cladogram of 655 *trans*-AT PKS KS domains from 54 characterized *trans*-AT PKS BGCs. *Cis*-AT PKS KS domains from the erythromycin PKS were used as outgroup. \* indicates ketide clades that can be further subdivided into sub-clades. \# indicates ketide clades that are first described in this study. The color code indicates similar ketide clade types. Outer circles around the central cladogram indicate the presence of a KS within the phyla with characterized *trans*-AT PKS BGCs. DB: double bonds; 3PG: 3-phosphoglycerate derived starters.](EMS83251-f001){#F1}

![TransATor workflow.\
Outline of the TransATor pipeline for protein-based analysis of *trans*-AT PKS BGCs. Core PKS domains are annotated and KS substrate specificities predicted based on HMMs. EMBOSS fuzzpro patterns are used to predict the absolute configuration of hydroxylated carbon atoms. CDK is used to construct the polyketide structure based on the PKS annotation. AH: acyl-hydrolase, CR: crotonase (syn: enoyl-CoA hydratase), ER: enoyl-reductase, *O*-MT: *O*-methyl-transferase, AL: acyl-ligase, GNAT: GCN5-related *N*-acetyltransferase, B: branching domain, MT: methyl-transferase, KR: ketoreductase, KS^0^: non-elongating KS, DH: dehydratase, PS: pyran synthase, A: adenylation domain, Cyc: cyclase, Ox: oxidase, small white circle: ACP. L: [l]{.smallcaps}-configured hydroxyl group, D: [d]{.smallcaps}-configured hydroxyl group. AMT: aminotransferase. C: condensation domain.](EMS83251-f002){#F2}

![Example of a TransATor result.\
(**a**) Bacillaene PKS. (**b**) Dihydrobacillaene structure predicted by TransATor. Confidence of prediction is indicated by grey scale representation with high-confidence annotations shown in black and lower-confidence annotations in grey. (**c**) TransATor-based PKS/NRPS annotation output. The \"viewer mode\" shows the annotated PKS/NRPS proteins. Colored boxes: HMM-based annotations. Top five hits for KS substrates are shown as turquoise bars. Information (e-value, specificity and if applicable stereochemical information) on all annotated domains can be obtained by hovering over the respective domain. A detailed list of the top five KS hits is displayed in the \"KS annotations\" view. The top hit is used for the generation of the predicted structure. Diamonds: KR-based hydroxyl group stereochemistry prediction. (**d**) Structures of dihydrobacillaene (**1**) and bacillaene (**2**).](EMS83251-f003){#F3}

![Model for leptolyngbyalide biosynthesis.\
**(a**) The *lept* BGC. Red: PKS genes, green: transporter genes, grey: hypothetical genes, purple: genes involved in lipid metabolism, brown: oxygenase genes, yellow: halogenase genes. **(b)** Comparison between TransATor-based structure prediction (**7**) and the AntiMarin library hits phormidolide (**8**) and oscillariolide (**9**). (**c**) Proposed model for the biosynthesis of isolated leptolyngbyalides A-C (**10-12**). Letters in white balls for the post-PKS steps refer to protein names according to [Supplementary Table 7](#SD2){ref-type="supplementary-material"}.](EMS83251-f004){#F4}

![Model for cuniculene biosynthesis.\
**(a)** Conserved *Aquimarina cun* BGC (here from *Aquimarina* sp. Ap349). Red: PKS genes, green: transporter genes, grey: hypothetical genes, light purple: aminotransferase genes/cysteine desulfurase, brown: oxygenase genes, blue: acyl-transferase-like gene. **(b)** Proposed model for cuniculene biosynthesis, predicted structure (**13**) and isolated compounds **14**-**15**. The biosynthetic model is based exclusively on TransATor predictions, with **13** displaying the core structure predicted by TransATor. The isolated compounds **14** and **15** are in perfect agreement with TransATor predictions. \* genes split between two contigs, putatively encoding one PKS protein.](EMS83251-f005){#F5}
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